data_1cfd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1cfd _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.23 0.538 . . . . 3.21 109.596 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -107.46 16.87 23.42 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.156 0.979 . . . . 3.18 108.783 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -62.22 149.07 42.76 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-O 121.61 0.719 . . . . 2.87 110.029 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.2 mt -72.61 125.37 27.3 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.693 -0.629 . . . . 1.11 109.346 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 p -69.99 156.29 39.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.112 -0.992 . . . . 1.29 109.154 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -54.47 -30.9 54.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.116 -0.99 . . . . 2.39 109.534 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -71.27 -57.61 4.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.881 . . . . 2.06 109.309 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -50.16 -35.18 25.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.976 . . . . 1.03 109.171 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.4 mt -70.1 -39.6 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.139 -0.975 . . . . 1.14 108.428 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.98 -48.72 65.02 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.396 -0.965 . . . . 1.09 108.396 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -49.97 -51.22 43.15 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 121.124 -0.985 . . . . 1.94 109.587 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -64.41 -41.3 96.71 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.889 -0.725 . . . . 1.49 109.129 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' HA ' ' CE1' ' A' ' 65' ' ' PHE . 1.3 ttmt -59.8 -36.67 77.22 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.406 -0.918 . . . . 1.86 109.391 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.02 -47.53 44.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.022 -1.049 . . . . 1.7 109.029 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.49 -28.13 69.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.417 -0.802 . . . . 1.05 108.908 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -76.43 -51.94 10.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.389 -0.819 . . . . 0.19 109.391 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.8 p -57.2 -30.3 64.42 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.512 -0.743 . . . . 1.79 109.609 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.478 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 5.9 mt -46.31 -27.68 1.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.936 . . . . 1.1 110.417 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.584 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 12.9 m-85 -121.02 28.6 7.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.214 -0.929 . . . . 0.2 110.126 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 26' ' ' THR . 13.2 t70 -99.79 63.75 1.23 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.015 -1.106 . . . . 1.12 108.015 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mmtt -73.74 -1.4 19.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.449 -0.782 . . . . 2.06 111.325 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.466 ' C ' ' N ' ' A' ' 24' ' ' ASP . 76.6 m-20 -99.73 5.49 45.66 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.345 -0.847 . . . . 1.21 109.639 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.95 18.56 0.78 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.871 -1.692 . . . . 0.38 108.871 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.466 ' N ' ' C ' ' A' ' 22' ' ' ASP . 26.3 t0 -99.86 -2.01 35.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.638 -0.919 . . . . 1.23 109.477 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.482 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 78.72 24.99 61.31 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.003 -1.239 . . . . 0.29 110.003 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.502 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 63.4 p -138.2 174.3 10.7 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.887 -1.361 . . . . 1.05 110.369 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.1 pt -140.93 167.23 17.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.522 -0.918 . . . . 1.02 108.522 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.8 p -93.04 166.3 12.43 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.964 -1.085 . . . . 1.07 109.558 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 p -69.29 -27.48 65.45 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.446 -0.784 . . . . 1.04 109.117 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -65.13 -25.8 67.92 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.343 -0.848 . . . . 2.52 110.123 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -99.78 -3.51 32.59 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.135 -0.978 . . . . 0.33 110.118 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.1 tp -53.81 -58.05 8.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.786 -1.196 . . . . 1.06 109.499 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -52.53 -44.3 59.32 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 108.695 -1.762 . . . . 0.22 108.695 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 m -57.7 -45.32 85.84 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.061 -1.258 . . . . 1.02 109.278 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.515 HG21 ' CD1' ' A' ' 19' ' ' PHE . 63.1 t -60.03 -57.6 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.766 -1.198 . . . . 1.04 107.766 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.9 mmt -54.27 -44.82 72.19 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.51 -0.744 . . . . 1.06 109.115 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 4.2 mtm180 -64.86 -27.59 68.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 3.04 108.865 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.2 p -62.45 -28.53 69.88 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.353 -0.842 . . . . 0.48 108.795 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.5 mt -88.07 1.05 55.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 1.06 109.541 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.71 13.26 57.04 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.996 -1.097 . . . . 0.28 111.119 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 7.4 mt-30 -99.89 142.03 31.92 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.804 -1.41 . . . . 2.64 108.835 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -132.34 73.76 76.81 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.835 -1.165 . . . . 1.87 110.932 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -67.36 150.07 80.92 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.604 1.536 . . . . 0.32 109.027 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.3 p -69.91 174.12 5.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.701 -1.249 . . . . 1.13 108.881 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -66.02 -44.11 85.69 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.242 -0.911 . . . . 2.07 109.631 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.02 -40.63 96.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.124 -0.985 . . . . 1.12 109.186 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.96 -39.02 80.4 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.08 -1.081 . . . . 1.37 108.08 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 36.6 mt -71.4 -46.57 59.95 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.473 -0.767 . . . . 1.19 109.79 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -65.84 -22.47 66.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 2.29 110.52 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.72 -47.99 28.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.103 -0.998 . . . . 2.06 109.056 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 53.2 mtm -67.2 -29.03 68.59 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.349 -0.844 . . . . 1.21 108.878 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 56' ' ' ASP . 61.3 mt -67.7 -43.45 86.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.334 -0.854 . . . . 1.16 109.17 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -56.04 -34.26 65.73 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.354 -0.841 . . . . 2.2 109.325 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -80.59 -49.79 10.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.901 . . . . 2.09 109.301 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.519 ' C ' ' H ' ' A' ' 57' ' ' ALA . 65.9 t -66.9 -29.09 45.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 122.06 0.934 . . . . 1.37 110.216 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 52' ' ' ILE . 27.8 t70 -79.65 37.96 0.36 Allowed 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 108.079 -1.082 . . . . 1.38 108.079 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -80.26 -23.07 41.06 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.611 0.72 . . . . 1.41 109.396 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -79.86 -19.06 49.18 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.932 -0.766 . . . . 1.97 108.932 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.88 16.06 77.88 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.043 -1.223 . . . . 0.98 110.043 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -99.77 -38.88 8.49 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.128 -1.219 . . . . 3.24 110.884 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.9 36.64 7.66 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.189 -1.164 . . . . 0.57 110.189 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.6 p -135.86 162.12 33.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.088 -1.242 . . . . 1.17 108.958 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.1 mt -131.33 132.37 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.088 -1.007 . . . . 1.05 108.977 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' OD1' ' C ' ' A' ' 64' ' ' ASP . 54.4 p30 -99.96 163.81 12.28 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.799 -1.186 . . . . 0.37 107.799 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.592 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 45.4 t80 -57.22 -49.95 90.99 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.95 -1.094 . . . . 1.86 112.005 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 5.8 Cg_exo -49.32 -55.25 4.32 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 120.98 1.12 . . . . 0.32 110.151 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -64.26 -31.92 73.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.08 -1.013 . . . . 0.49 109.06 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -63.17 -36.51 83.88 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.86 -1.163 . . . . 0.26 107.86 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.1 mt -68.05 -27.66 66.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 1.11 108.998 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.7 m -69.79 -26.62 64.35 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.539 -0.912 . . . . 1.08 108.539 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -47.9 19.57 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.441 -0.948 . . . . 1.43 108.441 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 77.6 mmm -58.55 -40.92 84.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.388 -0.82 . . . . 1.26 109.997 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.67 -28.25 67.54 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 120.99 -1.069 . . . . 1.07 109.743 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -76.41 -19.83 57.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.165 -0.96 . . . . 4.26 109.957 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.509 ' C ' ' H ' ' A' ' 77' ' ' LYS . 9.5 mmtp -94.09 -39.49 10.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.043 -1.036 . . . . 2.37 110.171 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -75.31 25.0 0.1 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.494 -0.754 . . . . 1.73 109.836 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.617 ' O ' ' N ' ' A' ' 79' ' ' THR . 20.8 mtpt -90.48 -87.5 0.19 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.045 0.926 . . . . 4.23 109.298 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -41.67 -14.51 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.692 -0.686 . . . . 2.27 111.317 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.617 ' N ' ' O ' ' A' ' 77' ' ' LYS . 8.9 t -115.38 45.53 1.64 Allowed 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.463 -0.773 . . . . 1.79 109.059 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -56.62 166.88 0.83 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.727 0.775 . . . . 2.32 109.553 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.73 -19.67 48.24 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.363 -1.717 . . . . 1.45 106.363 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -60.7 -45.3 94.74 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.632 -1.167 . . . . 2.1 109.491 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -61.84 -19.83 63.01 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.63 -0.669 . . . . 2.57 109.578 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -83.81 -42.71 16.17 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.369 -0.832 . . . . 2.04 109.857 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 85' ' ' ILE . 24.0 mt -72.96 -43.89 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.849 . . . . 1.1 108.954 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.76 ' HG3' HH11 ' A' ' 86' ' ' ARG . 1.6 ttm-85 -62.99 -39.88 96.07 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.344 -0.984 . . . . 3.61 108.344 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -68.01 -22.99 64.95 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.342 -0.943 . . . . 2.55 108.799 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.23 -46.3 18.12 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 106.707 -1.59 . . . . 1.26 106.707 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.404 ' HE1' ' HA ' ' A' ' 105' ' ' LEU . 22.6 m-85 -62.32 -27.01 68.74 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.011 -1.477 . . . . 0.47 107.011 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.648 HH11 ' CG ' ' A' ' 90' ' ' ARG . 0.1 OUTLIER -65.56 -45.34 83.74 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.903 -1.517 . . . . 3.66 106.903 177.505 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.2 t -55.9 -21.28 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.23 -1.026 . . . . 1.2 108.23 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.614 ' CG ' ' CG2' ' A' ' 108' ' ' VAL . 15.3 m-85 -99.72 -11.21 21.06 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.6 -0.687 . . . . 0.64 112.062 -176.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -91.19 61.49 4.52 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 108.128 -1.064 . . . . 1.53 108.128 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -59.73 -19.52 50.65 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.38 0.61 . . . . 3.88 111.088 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -99.46 9.41 43.3 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.447 -0.783 . . . . 3.18 110.082 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 46.14 32.84 5.14 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.72 -1.352 . . . . 2.36 109.72 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -99.39 -20.04 16.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.26 -1.141 . . . . 2.51 110.853 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.91 3.95 67.65 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.744 -1.342 . . . . 1.22 109.744 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -136.16 143.13 44.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.484 -1.009 . . . . 2.18 110.351 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 92' ' ' PHE . 10.0 pt -140.23 165.18 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.802 -1.185 . . . . 1.13 107.802 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 102' ' ' ALA . 96.0 p -74.86 139.78 43.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.847 -1.158 . . . . 1.06 108.993 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -40.47 -36.82 0.61 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.41 -0.806 . . . . 1.08 110.118 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.65 -54.4 46.53 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.071 -1.018 . . . . 1.1 108.585 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -59.71 -33.95 72.27 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.663 -0.865 . . . . 1.51 108.663 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.404 ' HA ' ' HE1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -67.46 -47.72 69.29 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.41 -0.959 . . . . 1.12 108.41 179.07 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.723 HH11 ' CB ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -64.0 -34.37 77.83 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.841 -1.17 . . . . 3.95 107.841 178.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.9 t60 -70.05 -40.59 75.02 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.914 -0.772 . . . . 0.94 108.914 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.614 ' CG2' ' CG ' ' A' ' 92' ' ' PHE . 77.2 t -58.76 -39.02 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 1.1 108.875 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.8 mtp -74.3 -30.56 62.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.492 -0.755 . . . . 0.96 110.878 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -85.31 -42.15 14.87 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.632 -1.292 . . . . 1.15 110.818 -178.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -63.17 -27.81 69.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.937 -1.102 . . . . 2.12 110.026 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 11.9 mt -60.09 -26.57 66.3 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.874 0.845 . . . . 1.24 110.393 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.54 28.24 19.95 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.526 -1.43 . . . . 1.34 109.526 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 116' ' ' LEU . 2.2 mt-10 -79.92 145.56 32.59 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.444 -1.033 . . . . 2.53 109.435 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -79.78 38.54 0.39 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.618 -1.301 . . . . 3.5 109.653 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 114' ' ' GLU . 26.0 mt -82.55 134.8 35.19 Favored 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 120.216 -0.594 . . . . 3.01 109.422 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 50.6 p -90.08 148.09 23.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 1.24 109.202 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -52.02 -27.92 15.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 1.34 109.68 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -70.67 -47.41 60.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 2.07 109.776 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.37 -41.02 72.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.104 -0.997 . . . . 0.69 109.435 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.49 -35.64 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.338 -0.851 . . . . 1.16 109.511 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -58.78 -35.02 72.12 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.362 -0.836 . . . . 1.15 109.271 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -42.91 51.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.204 -1.035 . . . . 2.62 108.204 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 63.5 mtt -59.7 -26.54 65.69 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.694 -0.854 . . . . 1.45 108.694 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.412 HD12 HG22 ' A' ' 125' ' ' ILE . 59.5 mt -79.22 -28.98 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.558 -0.713 . . . . 1.06 110.328 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.662 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.9 OUTLIER -55.32 -53.28 58.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.924 -1.11 . . . . 3.47 110.704 -179.062 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -79.43 -16.75 55.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.766 -1.209 . . . . 2.03 110.503 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.849 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -90.71 74.83 6.62 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.973 -1.492 . . . . 1.04 106.973 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.482 ' C ' ' O ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -38.89 79.41 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.477 1.132 . . . . 2.3 108.453 -178.385 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.849 ' N ' ' O ' ' A' ' 128' ' ' ALA . 0.3 OUTLIER -79.63 2.64 2.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 122.373 1.082 . . . . 1.21 111.664 -177.339 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.725 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.9 t0 -115.64 -151.78 0.49 Allowed 'General case' 0 C--N 1.264 -3.133 0 N-CA-C 107.034 -1.469 . . . . 1.56 107.034 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.61 ' H ' ' CG ' ' A' ' 131' ' ' ASP . . . 65.55 -25.34 0.13 Allowed Glycine 0 C--N 1.282 -2.468 0 N-CA-C 108.481 -1.848 . . . . 2.46 108.481 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.725 ' H ' ' C ' ' A' ' 131' ' ' ASP . 1.0 OUTLIER -135.22 -79.78 0.43 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.365 -1.079 . . . . 2.97 109.252 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 149.62 -29.43 1.17 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.968 -1.253 . . . . 0.91 109.968 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -121.91 148.34 44.87 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.365 -1.079 . . . . 1.78 108.963 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.48 148.71 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.08 -1.013 . . . . 1.13 109.484 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.465 ' OD1' ' C ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -78.57 165.52 23.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.875 -1.158 . . . . 3.23 107.875 178.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.479 ' O ' ' C ' ' A' ' 139' ' ' GLU . 0.4 OUTLIER -100.92 -29.72 12.05 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.065 -1.022 . . . . 2.21 112.241 -178.243 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 138' ' ' TYR . 8.7 tt0 -39.75 -39.69 0.82 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.425 -1.422 . . . . 2.58 110.268 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -72.75 -44.6 61.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.886 -1.134 . . . . 2.31 108.808 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -21.12 63.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.88 109.79 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 95.3 t -70.62 -50.04 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.856 -1.153 . . . . 1.22 109.233 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -62.01 -27.05 68.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.407 -0.808 . . . . 2.43 109.803 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.9 mtt -72.03 -37.36 69.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.213 -0.929 . . . . 1.67 110.012 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.0 mtm -73.1 -24.53 60.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.076 -1.015 . . . . 1.15 110.108 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -57.59 3.92 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.942 -1.099 . . . . 1.41 110.2 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -179.12 116.31 0.06 Allowed 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 122.068 0.937 . . . . 2.42 108.708 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.577 ' H ' ' CD ' ' A' ' 148' ' ' LYS . 2.2 mptp? . . . . . 0 C--N 1.287 -2.142 0 CA-C-O 117.958 -1.02 . . . . 5.57 109.567 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.23 0.538 . . . . 2.8700000000000001 109.596 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -107.46 16.87 23.42 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.156 0.979 . . . . 3.1800000000000002 108.783 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -62.22 149.07 42.76 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-O 121.61 0.719 . . . . 2.3900000000000001 110.029 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.2 mt -72.61 125.37 27.3 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.693 -0.629 . . . . 0.48999999999999999 109.346 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 p -69.99 156.29 39.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.112 -0.992 . . . . 0.57999999999999996 109.154 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -54.47 -30.9 54.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.116 -0.99 . . . . 2.3900000000000001 109.534 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -71.27 -57.61 4.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.881 . . . . 2.0600000000000001 109.309 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -50.16 -35.18 25.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.976 . . . . 0.80000000000000004 109.171 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.4 mt -70.1 -39.6 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.139 -0.975 . . . . 0.38 108.428 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.98 -48.72 65.02 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.396 -0.965 . . . . 0.44 108.396 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -49.97 -51.22 43.15 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 121.124 -0.985 . . . . 1.9399999999999999 109.587 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -64.41 -41.3 96.71 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.889 -0.725 . . . . 0.90000000000000002 109.129 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' HA ' ' CE1' ' A' ' 65' ' ' PHE . 1.3 ttmt -59.8 -36.67 77.22 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.406 -0.918 . . . . 1.3100000000000001 109.391 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.02 -47.53 44.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.022 -1.049 . . . . 1.7 109.029 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.609 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -62.49 -28.13 69.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.417 -0.802 . . . . 0.19 108.908 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -76.43 -51.94 10.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.389 -0.819 . . . . 0.17999999999999999 109.391 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.8 p -57.2 -30.3 64.42 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.512 -0.743 . . . . 1.3100000000000001 109.609 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.609 HD12 ' HA ' ' A' ' 15' ' ' ALA . 5.9 mt -46.31 -27.68 1.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.936 . . . . 0.28000000000000003 110.417 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.584 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 12.9 m-85 -121.02 28.6 7.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.214 -0.929 . . . . 0.20000000000000001 110.126 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 26' ' ' THR . 13.2 t70 -99.79 63.75 1.23 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.015 -1.106 . . . . 1.1200000000000001 108.015 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mmtt -73.74 -1.4 19.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.449 -0.782 . . . . 1.49 111.325 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.466 ' C ' ' N ' ' A' ' 24' ' ' ASP . 76.6 m-20 -99.73 5.49 45.66 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.345 -0.847 . . . . 1.21 109.639 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.95 18.56 0.78 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.871 -1.692 . . . . 0.35999999999999999 108.871 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.466 ' N ' ' C ' ' A' ' 22' ' ' ASP . 26.3 t0 -99.86 -2.01 35.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.638 -0.919 . . . . 1.23 109.477 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.482 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 78.72 24.99 61.31 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.003 -1.239 . . . . 0.27000000000000002 110.003 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.502 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 63.4 p -138.2 174.3 10.7 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.887 -1.361 . . . . 0.25 110.369 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.471 ' CD1' HG21 ' A' ' 35' ' ' VAL . 28.1 pt -140.93 167.23 17.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.522 -0.918 . . . . 0.19 108.522 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.8 p -93.04 166.3 12.43 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.964 -1.085 . . . . 0.22 109.558 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 p -69.29 -27.48 65.45 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.446 -0.784 . . . . 0.22 109.117 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -65.13 -25.8 67.92 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.343 -0.848 . . . . 2.0 110.123 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.408 ' O ' HG23 ' A' ' 35' ' ' VAL . 15.2 mt-10 -99.78 -3.51 32.59 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.135 -0.978 . . . . 0.33000000000000002 110.118 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.437 HD22 ' CD1' ' A' ' 63' ' ' ILE . 15.1 tp -53.81 -58.05 8.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.786 -1.196 . . . . 0.19 109.499 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -52.53 -44.3 59.32 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 108.695 -1.762 . . . . 0.20999999999999999 108.695 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 m -57.7 -45.32 85.84 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.061 -1.258 . . . . 0.23000000000000001 109.278 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.504 HG22 ' CD1' ' A' ' 19' ' ' PHE . 63.1 t -60.03 -57.6 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.766 -1.198 . . . . 0.17999999999999999 107.766 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.9 mmt -54.27 -44.82 72.19 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.51 -0.744 . . . . 0.92000000000000004 109.115 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 4.2 mtm180 -64.86 -27.59 68.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 2.4500000000000002 108.865 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.498 ' OG ' ' HB1' ' A' ' 15' ' ' ALA . 6.2 p -62.45 -28.53 69.88 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.353 -0.842 . . . . 0.28000000000000003 108.795 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.5 mt -88.07 1.05 55.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.28000000000000003 109.541 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.71 13.26 57.04 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.996 -1.097 . . . . 0.27000000000000002 111.119 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 7.4 mt-30 -99.89 142.03 31.92 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.804 -1.41 . . . . 2.0099999999999998 108.835 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -132.34 73.76 76.81 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.835 -1.165 . . . . 1.1799999999999999 110.932 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -67.36 150.07 80.92 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.604 1.536 . . . . 0.28999999999999998 109.027 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.3 p -69.91 174.12 5.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.701 -1.249 . . . . 0.45000000000000001 108.881 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -66.02 -44.11 85.69 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.242 -0.911 . . . . 2.0699999999999998 109.631 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.02 -40.63 96.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.124 -0.985 . . . . 0.42999999999999999 109.186 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.96 -39.02 80.4 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.08 -1.081 . . . . 1.3700000000000001 108.08 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 48' ' ' LEU . 36.6 mt -71.4 -46.57 59.95 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.473 -0.767 . . . . 0.38 109.79 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -65.84 -22.47 66.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 1.97 110.52 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.72 -47.99 28.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.103 -0.998 . . . . 2.0600000000000001 109.056 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 53.2 mtm -67.2 -29.03 68.59 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.349 -0.844 . . . . 0.68999999999999995 108.878 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.3 mt -67.7 -43.45 86.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.334 -0.854 . . . . 0.42999999999999999 109.17 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -56.04 -34.26 65.73 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.354 -0.841 . . . . 1.75 109.325 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -80.59 -49.79 10.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.901 . . . . 2.0899999999999999 109.301 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.484 ' C ' ' H ' ' A' ' 57' ' ' ALA . 65.9 t -66.9 -29.09 45.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 122.06 0.934 . . . . 0.81000000000000005 110.216 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -79.65 37.96 0.36 Allowed 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 108.079 -1.082 . . . . 1.3799999999999999 108.079 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -80.26 -23.07 41.06 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.611 0.72 . . . . 1.0800000000000001 109.396 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -79.86 -19.06 49.18 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.932 -0.766 . . . . 1.97 108.932 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.88 16.06 77.88 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.043 -1.223 . . . . 0.91000000000000003 110.043 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -99.77 -38.88 8.49 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.128 -1.219 . . . . 2.54 110.884 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.9 36.64 7.66 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.189 -1.164 . . . . 0.25 110.189 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.6 p -135.86 162.12 33.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.088 -1.242 . . . . 0.44 108.958 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.437 ' CD1' HD22 ' A' ' 32' ' ' LEU . 1.1 mt -131.33 132.37 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.088 -1.007 . . . . 0.20000000000000001 108.977 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' C ' ' OD1' ' A' ' 64' ' ' ASP . 54.4 p30 -99.96 163.81 12.28 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.799 -1.186 . . . . 0.37 107.799 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.61 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 45.4 t80 -57.22 -49.95 90.99 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.95 -1.094 . . . . 1.0600000000000001 112.005 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 5.8 Cg_exo -49.32 -55.25 4.32 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 120.98 1.12 . . . . 0.29999999999999999 110.151 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -64.26 -31.92 73.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.08 -1.013 . . . . 0.48999999999999999 109.06 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -63.17 -36.51 83.88 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.86 -1.163 . . . . 0.25 107.86 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.569 HD21 ' CZ ' ' A' ' 65' ' ' PHE . 11.1 mt -68.05 -27.66 66.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.31 108.998 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.7 m -69.79 -26.62 64.35 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.539 -0.912 . . . . 0.42999999999999999 108.539 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -47.9 19.57 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.441 -0.948 . . . . 0.82999999999999996 108.441 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 77.6 mmm -58.55 -40.92 84.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.388 -0.82 . . . . 1.05 109.997 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.67 -28.25 67.54 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 120.99 -1.069 . . . . 0.38 109.743 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -76.41 -19.83 57.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.165 -0.96 . . . . 3.6499999999999999 109.957 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 77' ' ' LYS . 9.5 mmtp -94.09 -39.49 10.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.043 -1.036 . . . . 1.9199999999999999 110.171 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -75.31 25.0 0.1 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.494 -0.754 . . . . 1.5700000000000001 109.836 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.617 ' O ' ' N ' ' A' ' 79' ' ' THR . 20.8 mtpt -90.48 -87.5 0.19 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.045 0.926 . . . . 3.8399999999999999 109.298 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -41.67 -14.51 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.692 -0.686 . . . . 2.27 111.317 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.617 ' N ' ' O ' ' A' ' 77' ' ' LYS . 8.9 t -115.38 45.53 1.64 Allowed 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.463 -0.773 . . . . 1.1899999999999999 109.059 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -56.62 166.88 0.83 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.727 0.775 . . . . 2.3199999999999998 109.553 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.73 -19.67 48.24 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.363 -1.717 . . . . 0.98999999999999999 106.363 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -60.7 -45.3 94.74 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.632 -1.167 . . . . 2.1000000000000001 109.491 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -61.84 -19.83 63.01 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.63 -0.669 . . . . 2.5699999999999998 109.578 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -83.81 -42.71 16.17 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.369 -0.832 . . . . 2.04 109.857 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.425 HG22 HG22 ' A' ' 142' ' ' VAL . 24.0 mt -72.96 -43.89 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.849 . . . . 0.47999999999999998 108.954 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.777 ' HG3' HH11 ' A' ' 86' ' ' ARG . 1.6 ttm-85 -62.99 -39.88 96.07 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.344 -0.984 . . . . 3.0600000000000001 108.344 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -68.01 -22.99 64.95 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.342 -0.943 . . . . 2.5499999999999998 108.799 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.493 ' HB2' HD21 ' A' ' 112' ' ' LEU . . . -79.23 -46.3 18.12 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 106.707 -1.59 . . . . 0.58999999999999997 106.707 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CD1' HG11 ' A' ' 108' ' ' VAL . 22.6 m-85 -62.32 -27.01 68.74 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.011 -1.477 . . . . 0.42999999999999999 107.011 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.66 ' CG ' HH11 ' A' ' 90' ' ' ARG . 0.1 OUTLIER -65.56 -45.34 83.74 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.903 -1.517 . . . . 3.0800000000000001 106.903 177.505 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 2.2 t -55.9 -21.28 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.23 -1.026 . . . . 0.56999999999999995 108.23 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 1.099 ' CD1' HG22 ' A' ' 108' ' ' VAL . 15.3 m-85 -99.72 -11.21 21.06 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.6 -0.687 . . . . 0.5 112.062 -176.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -91.19 61.49 4.52 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 108.128 -1.064 . . . . 1.53 108.128 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -59.73 -19.52 50.65 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.38 0.61 . . . . 3.52 111.088 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -99.46 9.41 43.3 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.447 -0.783 . . . . 3.1800000000000002 110.082 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 46.14 32.84 5.14 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.72 -1.352 . . . . 2.1899999999999999 109.72 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -99.39 -20.04 16.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.26 -1.141 . . . . 2.4300000000000002 110.853 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.91 3.95 67.65 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.744 -1.342 . . . . 1.02 109.744 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -136.16 143.13 44.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.484 -1.009 . . . . 1.3300000000000001 110.351 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.0 pt -140.23 165.18 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.802 -1.185 . . . . 0.38 107.802 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 102' ' ' ALA . 96.0 p -74.86 139.78 43.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.847 -1.158 . . . . 0.44 108.993 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -40.47 -36.82 0.61 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.41 -0.806 . . . . 0.28000000000000003 110.118 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.65 -54.4 46.53 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.071 -1.018 . . . . 0.38 108.585 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.798 ' O ' HG23 ' A' ' 108' ' ' VAL . 18.3 mt-10 -59.71 -33.95 72.27 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.663 -0.865 . . . . 1.2 108.663 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.427 ' HA ' ' HE1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -67.46 -47.72 69.29 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.41 -0.959 . . . . 0.33000000000000002 108.41 179.07 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.747 ' CB ' HH11 ' A' ' 106' ' ' ARG . 0.0 OUTLIER -64.0 -34.37 77.83 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.841 -1.17 . . . . 3.3199999999999998 107.841 178.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.9 t60 -70.05 -40.59 75.02 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.914 -0.772 . . . . 0.73999999999999999 108.914 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.099 HG22 ' CD1' ' A' ' 92' ' ' PHE . 77.2 t -58.76 -39.02 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.28000000000000003 108.875 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.8 mtp -74.3 -30.56 62.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.492 -0.755 . . . . 0.31 110.878 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -85.31 -42.15 14.87 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.632 -1.292 . . . . 0.42999999999999999 110.818 -178.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -63.17 -27.81 69.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.937 -1.102 . . . . 1.75 110.026 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.493 HD21 ' HB2' ' A' ' 88' ' ' ALA . 11.9 mt -60.09 -26.57 66.3 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.874 0.845 . . . . 0.90000000000000002 110.393 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.54 28.24 19.95 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.526 -1.43 . . . . 0.98999999999999999 109.526 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.408 ' C ' ' H ' ' A' ' 116' ' ' LEU . 2.2 mt-10 -79.92 145.56 32.59 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.444 -1.033 . . . . 2.5299999999999998 109.435 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -79.78 38.54 0.39 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.618 -1.301 . . . . 2.9199999999999999 109.653 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 114' ' ' GLU . 26.0 mt -82.55 134.8 35.19 Favored 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 120.216 -0.594 . . . . 2.46 109.422 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 50.6 p -90.08 148.09 23.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.64000000000000001 109.202 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -52.02 -27.92 15.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 1.3400000000000001 109.68 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -70.67 -47.41 60.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 2.0699999999999998 109.776 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.37 -41.02 72.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.104 -0.997 . . . . 0.68999999999999995 109.435 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.49 -35.64 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.338 -0.851 . . . . 0.48999999999999999 109.511 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -58.78 -35.02 72.12 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.362 -0.836 . . . . 1.1499999999999999 109.271 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -42.91 51.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.204 -1.035 . . . . 2.6200000000000001 108.204 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 63.5 mtt -59.7 -26.54 65.69 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.694 -0.854 . . . . 0.78000000000000003 108.694 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.5 mt -79.22 -28.98 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.558 -0.713 . . . . 0.35999999999999999 110.328 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.676 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.9 OUTLIER -55.32 -53.28 58.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.924 -1.11 . . . . 3.02 110.704 -179.062 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -79.43 -16.75 55.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.766 -1.209 . . . . 2.0299999999999998 110.503 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.849 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -90.71 74.83 6.62 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.973 -1.492 . . . . 0.37 106.973 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.482 ' C ' ' O ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -38.89 79.41 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.477 1.132 . . . . 2.2999999999999998 108.453 -178.385 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.849 ' N ' ' O ' ' A' ' 128' ' ' ALA . 0.3 OUTLIER -79.63 2.64 2.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 122.373 1.082 . . . . 1.05 111.664 -177.339 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.696 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.9 t0 -115.64 -151.78 0.49 Allowed 'General case' 0 C--N 1.264 -3.133 0 N-CA-C 107.034 -1.469 . . . . 1.5600000000000001 107.034 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.599 ' H ' ' CG ' ' A' ' 131' ' ' ASP . . . 65.55 -25.34 0.13 Allowed Glycine 0 C--N 1.282 -2.468 0 N-CA-C 108.481 -1.848 . . . . 2.4199999999999999 108.481 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.696 ' H ' ' C ' ' A' ' 131' ' ' ASP . 1.0 OUTLIER -135.22 -79.78 0.43 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.365 -1.079 . . . . 2.9700000000000002 109.252 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 149.62 -29.43 1.17 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.968 -1.253 . . . . 0.56999999999999995 109.968 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -121.91 148.34 44.87 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.365 -1.079 . . . . 1.6399999999999999 108.963 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.48 148.71 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.08 -1.013 . . . . 0.42999999999999999 109.484 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.478 HD21 ' CB ' ' A' ' 139' ' ' GLU . 0.1 OUTLIER -78.57 165.52 23.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.875 -1.158 . . . . 2.52 107.875 178.163 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.506 ' O ' HG23 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -100.92 -29.72 12.05 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.065 -1.022 . . . . 1.29 112.241 -178.243 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 138' ' ' TYR . 8.7 tt0 -39.75 -39.69 0.82 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.425 -1.422 . . . . 2.5800000000000001 110.268 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -72.75 -44.6 61.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.886 -1.134 . . . . 2.3100000000000001 108.808 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.403 ' CG ' HD21 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -69.87 -21.12 63.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.52000000000000002 109.79 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 138' ' ' TYR . 95.3 t -70.62 -50.04 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.856 -1.153 . . . . 0.57999999999999996 109.233 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -62.01 -27.05 68.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.407 -0.808 . . . . 2.0 109.803 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.9 mtt -72.03 -37.36 69.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.213 -0.929 . . . . 1.0600000000000001 110.012 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.0 mtm -73.1 -24.53 60.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.076 -1.015 . . . . 0.56000000000000005 110.108 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -57.59 3.92 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.942 -1.099 . . . . 1.0900000000000001 110.2 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -179.12 116.31 0.06 Allowed 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 122.068 0.937 . . . . 2.4199999999999999 108.708 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.672 ' H ' ' CD ' ' A' ' 148' ' ' LYS . 2.2 mptp? . . . . . 0 C--N 1.287 -2.142 0 CA-C-O 117.958 -1.02 . . . . 5.3099999999999996 109.567 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.23 0.538 . . . . 2.8700000000000001 109.596 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -107.46 16.87 23.42 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.156 0.979 . . . . 3.1800000000000002 108.783 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -62.22 149.07 42.76 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-O 121.61 0.719 . . . . 2.3900000000000001 110.029 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.2 mt -72.61 125.37 27.3 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.693 -0.629 . . . . 0.48999999999999999 109.346 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 p -69.99 156.29 39.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.112 -0.992 . . . . 0.57999999999999996 109.154 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -54.47 -30.9 54.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.116 -0.99 . . . . 2.3900000000000001 109.534 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -71.27 -57.61 4.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.881 . . . . 2.0600000000000001 109.309 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -50.16 -35.18 25.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.976 . . . . 0.80000000000000004 109.171 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.4 mt -70.1 -39.6 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.139 -0.975 . . . . 0.38 108.428 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.98 -48.72 65.02 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.396 -0.965 . . . . 0.44 108.396 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -49.97 -51.22 43.15 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 121.124 -0.985 . . . . 1.9399999999999999 109.587 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -64.41 -41.3 96.71 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.889 -0.725 . . . . 0.90000000000000002 109.129 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' HA ' ' CE1' ' A' ' 65' ' ' PHE . 1.3 ttmt -59.8 -36.67 77.22 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.406 -0.918 . . . . 1.3100000000000001 109.391 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -73.02 -47.53 44.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.022 -1.049 . . . . 1.7 109.029 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.609 ' HA ' HD12 ' A' ' 18' ' ' LEU . . . -62.49 -28.13 69.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.417 -0.802 . . . . 0.19 108.908 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -76.43 -51.94 10.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.389 -0.819 . . . . 0.17999999999999999 109.391 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.8 p -57.2 -30.3 64.42 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.512 -0.743 . . . . 1.3100000000000001 109.609 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.609 HD12 ' HA ' ' A' ' 15' ' ' ALA . 5.9 mt -46.31 -27.68 1.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.936 . . . . 0.28000000000000003 110.417 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.584 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 12.9 m-85 -121.02 28.6 7.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.214 -0.929 . . . . 0.20000000000000001 110.126 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 26' ' ' THR . 13.2 t70 -99.79 63.75 1.23 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.015 -1.106 . . . . 1.1200000000000001 108.015 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mmtt -73.74 -1.4 19.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.449 -0.782 . . . . 1.49 111.325 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.466 ' C ' ' N ' ' A' ' 24' ' ' ASP . 76.6 m-20 -99.73 5.49 45.66 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.345 -0.847 . . . . 1.21 109.639 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.95 18.56 0.78 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.871 -1.692 . . . . 0.35999999999999999 108.871 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.466 ' N ' ' C ' ' A' ' 22' ' ' ASP . 26.3 t0 -99.86 -2.01 35.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.638 -0.919 . . . . 1.23 109.477 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.482 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . 78.72 24.99 61.31 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.003 -1.239 . . . . 0.27000000000000002 110.003 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.502 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 63.4 p -138.2 174.3 10.7 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.887 -1.361 . . . . 0.25 110.369 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.471 ' CD1' HG21 ' A' ' 35' ' ' VAL . 28.1 pt -140.93 167.23 17.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.522 -0.918 . . . . 0.19 108.522 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.8 p -93.04 166.3 12.43 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.964 -1.085 . . . . 0.22 109.558 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 p -69.29 -27.48 65.45 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.446 -0.784 . . . . 0.22 109.117 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -65.13 -25.8 67.92 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.343 -0.848 . . . . 2.0 110.123 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.408 ' O ' HG23 ' A' ' 35' ' ' VAL . 15.2 mt-10 -99.78 -3.51 32.59 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.135 -0.978 . . . . 0.33000000000000002 110.118 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.437 HD22 ' CD1' ' A' ' 63' ' ' ILE . 15.1 tp -53.81 -58.05 8.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.786 -1.196 . . . . 0.19 109.499 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -52.53 -44.3 59.32 Favored Glycine 0 N--CA 1.483 1.793 0 N-CA-C 108.695 -1.762 . . . . 0.20999999999999999 108.695 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 m -57.7 -45.32 85.84 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.061 -1.258 . . . . 0.23000000000000001 109.278 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.504 HG22 ' CD1' ' A' ' 19' ' ' PHE . 63.1 t -60.03 -57.6 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.766 -1.198 . . . . 0.17999999999999999 107.766 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.9 mmt -54.27 -44.82 72.19 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.51 -0.744 . . . . 0.92000000000000004 109.115 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 4.2 mtm180 -64.86 -27.59 68.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 2.4500000000000002 108.865 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.498 ' OG ' ' HB1' ' A' ' 15' ' ' ALA . 6.2 p -62.45 -28.53 69.88 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.353 -0.842 . . . . 0.28000000000000003 108.795 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.5 mt -88.07 1.05 55.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.28000000000000003 109.541 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.71 13.26 57.04 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.996 -1.097 . . . . 0.27000000000000002 111.119 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 7.4 mt-30 -99.89 142.03 31.92 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.804 -1.41 . . . . 2.0099999999999998 108.835 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -132.34 73.76 76.81 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 120.835 -1.165 . . . . 1.1799999999999999 110.932 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -67.36 150.07 80.92 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.604 1.536 . . . . 0.28999999999999998 109.027 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.3 p -69.91 174.12 5.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.701 -1.249 . . . . 0.45000000000000001 108.881 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -66.02 -44.11 85.69 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.242 -0.911 . . . . 2.0699999999999998 109.631 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.02 -40.63 96.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.124 -0.985 . . . . 0.42999999999999999 109.186 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.96 -39.02 80.4 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.08 -1.081 . . . . 1.3700000000000001 108.08 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 48' ' ' LEU . 36.6 mt -71.4 -46.57 59.95 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.473 -0.767 . . . . 0.38 109.79 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -65.84 -22.47 66.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 1.97 110.52 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.72 -47.99 28.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.103 -0.998 . . . . 2.0600000000000001 109.056 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 53.2 mtm -67.2 -29.03 68.59 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.349 -0.844 . . . . 0.68999999999999995 108.878 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 61.3 mt -67.7 -43.45 86.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.334 -0.854 . . . . 0.42999999999999999 109.17 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -56.04 -34.26 65.73 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.354 -0.841 . . . . 1.75 109.325 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -80.59 -49.79 10.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.901 . . . . 2.0899999999999999 109.301 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.484 ' C ' ' H ' ' A' ' 57' ' ' ALA . 65.9 t -66.9 -29.09 45.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 122.06 0.934 . . . . 0.81000000000000005 110.216 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -79.65 37.96 0.36 Allowed 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 108.079 -1.082 . . . . 1.3799999999999999 108.079 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 55' ' ' VAL . . . -80.26 -23.07 41.06 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.611 0.72 . . . . 1.0800000000000001 109.396 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -79.86 -19.06 49.18 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.932 -0.766 . . . . 1.97 108.932 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.88 16.06 77.88 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.043 -1.223 . . . . 0.91000000000000003 110.043 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -99.77 -38.88 8.49 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.128 -1.219 . . . . 2.54 110.884 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.9 36.64 7.66 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.189 -1.164 . . . . 0.25 110.189 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.6 p -135.86 162.12 33.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.088 -1.242 . . . . 0.44 108.958 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.437 ' CD1' HD22 ' A' ' 32' ' ' LEU . 1.1 mt -131.33 132.37 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.088 -1.007 . . . . 0.20000000000000001 108.977 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' C ' ' OD1' ' A' ' 64' ' ' ASP . 54.4 p30 -99.96 163.81 12.28 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.799 -1.186 . . . . 0.37 107.799 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.61 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 45.4 t80 -57.22 -49.95 90.99 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.95 -1.094 . . . . 1.0600000000000001 112.005 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 5.8 Cg_exo -49.32 -55.25 4.32 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 120.98 1.12 . . . . 0.29999999999999999 110.151 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -64.26 -31.92 73.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.08 -1.013 . . . . 0.48999999999999999 109.06 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -63.17 -36.51 83.88 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.86 -1.163 . . . . 0.25 107.86 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.569 HD21 ' CZ ' ' A' ' 65' ' ' PHE . 11.1 mt -68.05 -27.66 66.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.384 -0.822 . . . . 0.31 108.998 178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.7 m -69.79 -26.62 64.35 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.539 -0.912 . . . . 0.42999999999999999 108.539 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -47.9 19.57 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.441 -0.948 . . . . 0.82999999999999996 108.441 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 77.6 mmm -58.55 -40.92 84.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.388 -0.82 . . . . 1.05 109.997 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.67 -28.25 67.54 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 120.99 -1.069 . . . . 0.38 109.743 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -76.41 -19.83 57.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.165 -0.96 . . . . 3.6499999999999999 109.957 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 77' ' ' LYS . 9.5 mmtp -94.09 -39.49 10.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.043 -1.036 . . . . 1.9199999999999999 110.171 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -75.31 25.0 0.1 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.494 -0.754 . . . . 1.5700000000000001 109.836 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.617 ' O ' ' N ' ' A' ' 79' ' ' THR . 20.8 mtpt -90.48 -87.5 0.19 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 122.045 0.926 . . . . 3.8399999999999999 109.298 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -41.67 -14.51 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.692 -0.686 . . . . 2.27 111.317 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.617 ' N ' ' O ' ' A' ' 77' ' ' LYS . 8.9 t -115.38 45.53 1.64 Allowed 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.463 -0.773 . . . . 1.1899999999999999 109.059 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -56.62 166.88 0.83 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.727 0.775 . . . . 2.3199999999999998 109.553 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.73 -19.67 48.24 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.363 -1.717 . . . . 0.98999999999999999 106.363 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -60.7 -45.3 94.74 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.632 -1.167 . . . . 2.1000000000000001 109.491 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -61.84 -19.83 63.01 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.63 -0.669 . . . . 2.5699999999999998 109.578 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -83.81 -42.71 16.17 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.369 -0.832 . . . . 2.04 109.857 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.425 HG22 HG22 ' A' ' 142' ' ' VAL . 24.0 mt -72.96 -43.89 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.849 . . . . 0.47999999999999998 108.954 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.777 ' HG3' HH11 ' A' ' 86' ' ' ARG . 1.6 ttm-85 -62.99 -39.88 96.07 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.344 -0.984 . . . . 3.0600000000000001 108.344 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -68.01 -22.99 64.95 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.342 -0.943 . . . . 2.5499999999999998 108.799 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.493 ' HB2' HD21 ' A' ' 112' ' ' LEU . . . -79.23 -46.3 18.12 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 106.707 -1.59 . . . . 0.58999999999999997 106.707 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CD1' HG11 ' A' ' 108' ' ' VAL . 22.6 m-85 -62.32 -27.01 68.74 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.011 -1.477 . . . . 0.42999999999999999 107.011 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.66 ' CG ' HH11 ' A' ' 90' ' ' ARG . 0.1 OUTLIER -65.56 -45.34 83.74 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.903 -1.517 . . . . 3.0800000000000001 106.903 177.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 2.2 t -55.9 -21.28 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.23 -1.026 . . . . 0.56999999999999995 108.23 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 1.099 ' CD1' HG22 ' A' ' 108' ' ' VAL . 15.3 m-85 -99.72 -11.21 21.06 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.6 -0.687 . . . . 0.5 112.062 -176.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -91.19 61.49 4.52 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 108.128 -1.064 . . . . 1.53 108.128 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -59.73 -19.52 50.65 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.38 0.61 . . . . 3.52 111.088 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -99.46 9.41 43.3 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 121.447 -0.783 . . . . 3.1800000000000002 110.082 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 46.14 32.84 5.14 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.72 -1.352 . . . . 2.1899999999999999 109.72 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -99.39 -20.04 16.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.26 -1.141 . . . . 2.4300000000000002 110.853 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.91 3.95 67.65 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.744 -1.342 . . . . 1.02 109.744 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -136.16 143.13 44.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.484 -1.009 . . . . 1.3300000000000001 110.351 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 10.0 pt -140.23 165.18 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.802 -1.185 . . . . 0.38 107.802 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 102' ' ' ALA . 96.0 p -74.86 139.78 43.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.847 -1.158 . . . . 0.44 108.993 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -40.47 -36.82 0.61 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.41 -0.806 . . . . 0.28000000000000003 110.118 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.65 -54.4 46.53 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.071 -1.018 . . . . 0.38 108.585 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.798 ' O ' HG23 ' A' ' 108' ' ' VAL . 18.3 mt-10 -59.71 -33.95 72.27 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.663 -0.865 . . . . 1.2 108.663 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.427 ' HA ' ' HE1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -67.46 -47.72 69.29 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.41 -0.959 . . . . 0.33000000000000002 108.41 179.07 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.747 ' CB ' HH11 ' A' ' 106' ' ' ARG . 0.0 OUTLIER -64.0 -34.37 77.83 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.841 -1.17 . . . . 3.3199999999999998 107.841 178.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.9 t60 -70.05 -40.59 75.02 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.914 -0.772 . . . . 0.73999999999999999 108.914 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.099 HG22 ' CD1' ' A' ' 92' ' ' PHE . 77.2 t -58.76 -39.02 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.28000000000000003 108.875 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.8 mtp -74.3 -30.56 62.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.492 -0.755 . . . . 0.31 110.878 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -85.31 -42.15 14.87 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.632 -1.292 . . . . 0.42999999999999999 110.818 -178.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -63.17 -27.81 69.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.937 -1.102 . . . . 1.75 110.026 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.493 HD21 ' HB2' ' A' ' 88' ' ' ALA . 11.9 mt -60.09 -26.57 66.3 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.874 0.845 . . . . 0.90000000000000002 110.393 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 89.54 28.24 19.95 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.526 -1.43 . . . . 0.98999999999999999 109.526 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.408 ' C ' ' H ' ' A' ' 116' ' ' LEU . 2.2 mt-10 -79.92 145.56 32.59 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.444 -1.033 . . . . 2.5299999999999998 109.435 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -79.78 38.54 0.39 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.618 -1.301 . . . . 2.9199999999999999 109.653 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 114' ' ' GLU . 26.0 mt -82.55 134.8 35.19 Favored 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 120.216 -0.594 . . . . 2.46 109.422 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 50.6 p -90.08 148.09 23.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.64000000000000001 109.202 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -52.02 -27.92 15.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 1.3400000000000001 109.68 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -70.67 -47.41 60.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 2.0699999999999998 109.776 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.37 -41.02 72.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.104 -0.997 . . . . 0.68999999999999995 109.435 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.49 -35.64 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.338 -0.851 . . . . 0.48999999999999999 109.511 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -58.78 -35.02 72.12 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.362 -0.836 . . . . 1.1499999999999999 109.271 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.49 -42.91 51.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.204 -1.035 . . . . 2.6200000000000001 108.204 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 63.5 mtt -59.7 -26.54 65.69 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.694 -0.854 . . . . 0.78000000000000003 108.694 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.5 mt -79.22 -28.98 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.558 -0.713 . . . . 0.35999999999999999 110.328 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.676 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.9 OUTLIER -55.32 -53.28 58.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.924 -1.11 . . . . 3.02 110.704 -179.062 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -79.43 -16.75 55.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.766 -1.209 . . . . 2.0299999999999998 110.503 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.849 ' O ' ' N ' ' A' ' 130' ' ' ILE . . . -90.71 74.83 6.62 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.973 -1.492 . . . . 0.37 106.973 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.482 ' C ' ' O ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -38.89 79.41 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.477 1.132 . . . . 2.2999999999999998 108.453 -178.385 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.849 ' N ' ' O ' ' A' ' 128' ' ' ALA . 0.3 OUTLIER -79.63 2.64 2.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 122.373 1.082 . . . . 1.05 111.664 -177.339 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.696 ' C ' ' H ' ' A' ' 133' ' ' ASP . 44.9 t0 -115.64 -151.78 0.49 Allowed 'General case' 0 C--N 1.264 -3.133 0 N-CA-C 107.034 -1.469 . . . . 1.5600000000000001 107.034 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.599 ' H ' ' CG ' ' A' ' 131' ' ' ASP . . . 65.55 -25.34 0.13 Allowed Glycine 0 C--N 1.282 -2.468 0 N-CA-C 108.481 -1.848 . . . . 2.4199999999999999 108.481 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.696 ' H ' ' C ' ' A' ' 131' ' ' ASP . 1.0 OUTLIER -135.22 -79.78 0.43 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.365 -1.079 . . . . 2.9700000000000002 109.252 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 149.62 -29.43 1.17 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.968 -1.253 . . . . 0.56999999999999995 109.968 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -121.91 148.34 44.87 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.365 -1.079 . . . . 1.6399999999999999 108.963 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.48 148.71 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.08 -1.013 . . . . 0.42999999999999999 109.484 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.478 HD21 ' CB ' ' A' ' 139' ' ' GLU . 0.1 OUTLIER -78.57 165.52 23.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.875 -1.158 . . . . 2.52 107.875 178.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.506 ' O ' HG23 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -100.92 -29.72 12.05 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.065 -1.022 . . . . 1.29 112.241 -178.243 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 138' ' ' TYR . 8.7 tt0 -39.75 -39.69 0.82 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.425 -1.422 . . . . 2.5800000000000001 110.268 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -72.75 -44.6 61.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.886 -1.134 . . . . 2.3100000000000001 108.808 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.403 ' CG ' HD21 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -69.87 -21.12 63.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.866 . . . . 0.52000000000000002 109.79 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 138' ' ' TYR . 95.3 t -70.62 -50.04 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.856 -1.153 . . . . 0.57999999999999996 109.233 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -62.01 -27.05 68.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.407 -0.808 . . . . 2.0 109.803 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.9 mtt -72.03 -37.36 69.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.213 -0.929 . . . . 1.0600000000000001 110.012 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.0 mtm -73.1 -24.53 60.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.076 -1.015 . . . . 0.56000000000000005 110.108 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -57.59 3.92 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.942 -1.099 . . . . 1.0900000000000001 110.2 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -179.12 116.31 0.06 Allowed 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 122.068 0.937 . . . . 2.4199999999999999 108.708 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.672 ' H ' ' CD ' ' A' ' 148' ' ' LYS . 2.2 mptp? . . . . . 0 C--N 1.287 -2.142 0 CA-C-O 117.958 -1.02 . . . . 5.3099999999999996 109.567 -179.807 . . . . . . . . 1 1 . 1 stop_ save_